A comparison of peripheral blood coculture versus 18- or 24-month serology in the diagnosis of human immunodeficiency virus infection in the offspring of infected mothers

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 560-563

  McIntosh, Kenneth ^a   Fitzgerald, Gordon ^b   Pitt, Jane ^b   Bremer, James W ^b   Hillyer, George V ^b   Landesman, Sheldon ^b   Rosenblatt, Howard ^b   Lew, Judy F ^b   Davenny, Katherine ^b   Moye, Jack ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G;

ARTICLE; BLOOD CULTURE; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MATERNAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; SEROLOGY; VIRUS CULTURE;

EID: 17344367863     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517474     Document Type: Article

References (14)

1. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994; 170:996-1000.
2. Bremer JW, Lew JF, Cooper E, et al. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr 1996; 129:198-207.
3. Steketee RW, Abrams EJ, Thea DM, et al. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. J Infect Dis 1997; 175:707-11.
4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994:331:1173-80.
5. Centers for Disease Control and Prevention. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to HIV. MMWR Morb Mortal Wkly Rep 1995;44(RR-4).
6. Hollinger FB, Bremer JW, Myers LE, et al. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multi center quality assurance program for the AIDS Clinical Trials Group. J Clin Microbiol 1992;30:1787-94.
7. Hollinger FB, Bremer JW, Myers L, Gupta P, Meyer W. HIV quantitation by dilutional micrococulture: development, standardization, and quality control implementation in a multi-center clinical trials setting [abstract 6073]. In: Program and abstracts: VIII International Conference on AIDS/III STD World Congress (Amsterdam). Amsterdam: Congrex Holland, 1992:23.
8. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12).
9. Landay AL, Brambilla D, Pitt J, et al. Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. Clin Diagn Lab Immunol 1995;2:462-8.
10. Pitt J, Brambilla D. Reichelderfer P, et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 (HIV-1) infection: findings from the Women and Infants Transmission Study. J Infect Dis 1997; 175:567-75.
11. Borkowsky W, Krasinski K, Paul D, Moore T, Bebenroth D, Chandwani S. Human-immunodeficiency-virus infection in infants negative for anti-HIV by enzyme-linked immunoassay. Lancet 1987;1:1168-71.
12. Jones DS, Abrams E, Ou CY, et al. Lack of detectable human immunodeficiency virus infection in antibody-negative children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 1993; 12:222-7.
13. Wiznia AA, Lambert G, Dobrosyzcki J, et al. Virologie, immunologic, and clinical evaluation of human immunodeficiency virus antibody status of symptom-free children born to infected mothers. J Pediatr 1994; 125: 352-5.
14. Simpson BJ, Andiman WA. Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics 1994;93:840-2.